Medsafe Logo


INFORMATION FOR HEALTH PROFESSIONALS

Home  |  Consumers  |  Health Professionals  |  Regulatory  |  Other  |  Hot Topics  |  Search

Prescriber Update Articles

Web site: June 2011
Prescriber Update 2011;32(2):18

WE NEED YOUR HELP!

Please send your reports for these potential safety issues* listed in the table below.

Medicine Potential safety issue Active monitoring period ends*
Rivaroxaban Atrial fibrillation 1 September 2011
Simvastatin Joint pain and swelling 1 September 2011
Quetiapine cardiomyopathy 1 September 2011

 





newzealand.govt.nz - connecting you to New Zealand central & local government services


newzealand.govt.nz